Vapreotide: Difference between revisions

Vapreotide
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

← Older edit Newer edit →

Revision as of 03:54, 13 February 2025

A synthetic somatostatin analog used in medicine

Vapreotide is a synthetic somatostatin analog used primarily in the treatment of certain medical conditions such as esophageal varices and acromegaly. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.

Pharmacology

Vapreotide functions by binding to somatostatin receptors, which are G-protein-coupled receptors found throughout the body. This binding inhibits the secretion of various hormones, including growth hormone, insulin, and glucagon.

Mechanism of Action

The primary mechanism of action of vapreotide involves its interaction with somatostatin receptors, particularly the SSTR2 and SSTR5 subtypes. By activating these receptors, vapreotide reduces the release of growth hormone and other peptides, which can be beneficial in conditions like acromegaly and gastrointestinal bleeding.

Medical Uses

Vapreotide is used in the management of:

Acromegaly: A condition characterized by excessive growth hormone production, leading to enlarged bones and tissues.
Esophageal varices: Dilated veins in the esophagus that can bleed, often associated with liver cirrhosis.

Administration

Vapreotide is typically administered via intravenous or subcutaneous injection. The dosage and frequency depend on the specific condition being treated and the patient's response to therapy.

Side Effects

Common side effects of vapreotide include:

Related Pages

@@ Line 1: / Line 1: @@
-{{Short description|Synthetic somatostatin analog}}
+{{Short description|A synthetic somatostatin analog used in medicine}}
-{{Use dmy dates|date=October 2023}}
+{{Drugbox
-[[File:Vapreotide.svg|thumb|Chemical structure of Vapreotide]]
+| verifiedfields = changed
-'''Vapreotide''' is a synthetic [[somatostatin]] analog used primarily in the treatment of certain types of [[cancer]] and [[gastrointestinal]] disorders. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.
+| verifiedrevid = 477002123
+| image = Vapreotide.svg
+| image2 = <!-- Another image if available -->
+}}
+'''Vapreotide''' is a synthetic [[somatostatin]] analog used primarily in the treatment of certain medical conditions such as [[esophageal varices]] and [[acromegaly]]. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.
 ==Pharmacology==
-Vapreotide is a [[cyclic peptide]] that acts as an agonist at somatostatin receptors. It has a high affinity for the [[somatostatin receptor]] subtypes 2, 3, and 5. By binding to these receptors, vapreotide inhibits the secretion of [[growth hormone]], [[insulin]], and [[glucagon]].
+Vapreotide functions by binding to somatostatin receptors, which are G-protein-coupled receptors found throughout the body. This binding inhibits the secretion of various hormones, including [[growth hormone]], [[insulin]], and [[glucagon]].
-==Medical uses==
+===Mechanism of Action===
-Vapreotide is used in the management of [[acromegaly]], a condition characterized by excessive production of growth hormone. It is also employed in the treatment of [[gastrointestinal bleeding]] associated with [[esophageal varices]] in patients with [[cirrhosis]].
+The primary mechanism of action of vapreotide involves its interaction with somatostatin receptors, particularly the SSTR2 and SSTR5 subtypes. By activating these receptors, vapreotide reduces the release of growth hormone and other peptides, which can be beneficial in conditions like acromegaly and [[gastrointestinal bleeding]].
-==Mechanism of action==
+==Medical Uses==
-The drug works by mimicking the action of somatostatin, thereby reducing the secretion of various hormones and [[neurotransmitters]]. This action helps in controlling symptoms associated with hormone-secreting tumors and other related conditions.
+Vapreotide is used in the management of:
-==Side effects==
+* [[Acromegaly]]: A condition characterized by excessive growth hormone production, leading to enlarged bones and tissues.
-Common side effects of vapreotide include [[nausea]], [[vomiting]], [[diarrhea]], and [[abdominal pain]]. Long-term use may lead to [[gallstone]] formation due to reduced gallbladder motility.
+* [[Esophageal varices]]: Dilated veins in the esophagus that can bleed, often associated with [[liver cirrhosis]].
-==History==
+==Administration==
-Vapreotide was developed as part of efforts to create longer-acting and more potent analogs of somatostatin. It has been studied extensively for its potential benefits in treating various endocrine and gastrointestinal disorders.
+Vapreotide is typically administered via [[intravenous]] or [[subcutaneous injection]]. The dosage and frequency depend on the specific condition being treated and the patient's response to therapy.
-==Research==
+==Side Effects==
-Ongoing research is exploring the use of vapreotide in other conditions, such as [[neuroendocrine tumors]] and [[pancreatic cancer]]. Studies are also investigating its efficacy in combination with other therapeutic agents.
+Common side effects of vapreotide include:
-==Related pages==
+* [[Nausea]]
+* [[Diarrhea]]
+* [[Abdominal pain]]
+* [[Injection site reactions]]
+==Related Pages==
 * [[Somatostatin]]
 * [[Somatostatin receptor]]
@@ Line 28: / Line 38: @@
 * [[Esophageal varices]]
-==References==
+[[Category:Peptide hormones]]
-{{Reflist}}
+[[Category:Somatostatin analogs]]
+[[Category:Endocrinology]]
-[[Category:Peptides]]
-[[Category:Hormones]]
-[[Category:Antineoplastic and immunomodulating agents]]
-[[Category:Somatostatin receptor agonists]]